Insecticides (India) Ltd. Presents Q4 & FY26 Earnings Presentation
Insecticides (India) Limited released its Q4 & FY26 earnings presentation. FY26 revenue reached ₹2,140 crore, a 7% increase. Gross Profit was ₹675 crore, EBITDA ₹227 crore, and PAT ₹139 crore. The company highlighted growth in premium product sales and its strong distribution network.
The release of an earnings presentation with detailed financial results and operational updates provides significant information to investors and stakeholders, influencing investment decisions and market perception.
The announcement is an earnings presentation which provides factual financial and operational data. While the performance metrics show growth, there are also some areas of slight decline (e.g., Q4 EBITDA and PAT year-on-year), making the overall sentiment neutral.
Insecticides (India) Limited has released its Earning Presentation for the fourth quarter and financial year ended March 31, 2026. The presentation, dated May 2026, covers key financial and operational highlights for Q4 FY26 and the full fiscal year FY26.
Key financial metrics for FY26 show a 7% increase in Revenue from Operations to ₹2,140 crore, with Gross Profit at ₹675 crore and EBITDA at ₹227 crore. Profit After Tax (PAT) stood at ₹139 crore. The company noted an improvement in its Gross Profit Margin to 31.5% and EBITDA Margin to 10.6% for FY26. The B2C segment continues to be a significant contributor, with premium products making up 58% of B2C sales in FY26, up from 51% in FY23.
The presentation also details operational strengths, including an integrated manufacturing setup with multiple plants, a robust R&D infrastructure with 27 patents, and an extensive FMCG-style distribution network reaching over 70,000 retailers and 8,500 distributors. The company emphasizes its commitment to innovation, farmer connect, and sustainable value creation through its 'Fundamental Pillars'.
Environmental, Social, and Governance (ESG) initiatives are also highlighted, including the use of renewable energy sources, zero liquid discharge policies in some plants, and efforts to reduce carbon footprint. The company has also received several awards and recognitions for its performance and CSR activities.
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.